Wuhan Woyi Biotechnology Co., Ltd.

Wuhan Woyi Biotechnology Co., Ltd. is a high-tech enterprise established in March 2012 in the East Lake High-tech Development Zone (also a 3551 Talent Enterprise), with a registered capital of 25 million yuan. Headquartered in Wuhan Optics Valley, one of China's first optoelectronics industrial bases, the company is mainly engaged in the research and development, production, and sales of brain neuroscience and biological tissue three-dimensional imaging equipment, committed to providing fundamental tools for brain science research and serving the strategic direction of national scientific and technological innovation. Since its founding, adhering to the business philosophy of "integrity, professionalism, and innovation," the company has launched a series of products with advanced levels and holds multiple invention patents.
Based on a series of instruments and equipment utilizing Micro-Optical Sectioning Tomography (MOST) technology, the company has taken the lead internationally in establishing three-dimensional imaging of fine structures at the neurite level for centimeter-sized samples, filling the gap between magnetic resonance imaging and electron microscopy imaging. This technology was awarded one of China's Top Ten Scientific Advances in 2011 and the Second Prize of the National Technological Invention Award in 2014.
The series of equipment can not only obtain single-cell resolution whole-brain connectivity maps of mice, precise whole-brain localization of neural circuits, and long-range projection tracking of neurons, but can also be used for three-dimensional fine imaging and reconstruction of neural and vascular network changes during normal, disease, and developmental processes, as well as various tissues and organs, in various model animals such as Drosophila, zebrafish, mice, rats, and primates. This series of equipment will become a fundamental research tool in fields such as brain science research, brain disease prevention and treatment, tumor diagnosis, exploration of the essence of consciousness, and artificial intelligence.
Our team has extensive professional knowledge and experience in developing optical imaging instruments, and employees with a master's degree or above account for 46% of the total staff.
The company adheres to a market-oriented approach, focuses on technological innovation, aims to meet customer needs, and strives to achieve win-win results and common development together with customers.